Kevin Shumrick, MD
Otolaryngology/Facial Plastic Surgery · Cincinnati, OHNPI 1437194800
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Synthes GmbH accounts for 93.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $3,783 and has fallen 97.1% since, to $108 in 2025.
Across 19 payments — averaging $339.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$6K
- Aerin Medical Inc.$157
- GSK$125
- Regeneron Healthcare Solutions, Inc.$77
- Merck$40
- Integra Lifesciences Corporation$25
- plus $17 from 1 others
What the payments were for
- Speaking & faculty fees$3,70057%
- Travel & lodging$2,16734%
- Food & beverage$5909%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 8 | $6,016 |
| Aerin Medical Inc. | 2 | $157 |
| GSK | 2 | $125 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Merck | 2 | $40 |
| Integra Lifesciences Corporation | 1 | $25 |
| Optinose US, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vivaer RF Stylus$142
- NUCALA$104
How this compares
$6,457 in reported general payments places this provider in the 85th percentile of 29 otolaryngology/facial plastic surgery providers in Ohio.
See all otolaryngology/facial plastic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 72 | $263 |
| Tramadol Hcl | 75 | $145 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Cincinnati
- Tsung-Yen HsiehCincinnati$9K
- Mark GrosingerCincinnati$1K
- David MoradCincinnati$174
- Howard LevineCleveland$65K
- Joseph ScharpfCleveland$12K
- Matthew LutzStow$6K
- Avi ShawBoardman$6K
- Ryan GerritsenAkron$5K
- Eric LamarreCleveland$4K
- Phillip KhalilStow$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.